Daniel Weintraub Selected Research

Dizziness (Lightheadedness)

1/2016	Rasagiline for mild cognitive impairment in Parkinson's disease: A placebo-controlled trial.
4/2010	Sertraline for the treatment of depression in Alzheimer disease: week-24 outcomes.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Daniel Weintraub Research Topics

Disease

99	Parkinson Disease (Parkinson's Disease) 05/2024 - 12/2003
49	Dementia (Dementias) 05/2024 - 08/2003
49	Alzheimer Disease (Alzheimer's Disease) 01/2024 - 12/2003
45	Cognitive Dysfunction 02/2024 - 10/2006
17	Psychotic Disorders (Schizoaffective Disorder) 12/2023 - 10/2006
15	Disruptive, Impulse Control, and Conduct Disorders (Kleptomania) 06/2023 - 07/2006
9	Disease Progression 01/2024 - 01/2015
7	Hallucinations (Hallucination) 12/2022 - 05/2016
7	Neurodegenerative Diseases (Neurodegenerative Disease) 06/2022 - 01/2017
7	Atrophy 01/2022 - 12/2011
6	Synucleinopathies 01/2024 - 02/2013
6	Gambling (Pathological Gambling) 01/2020 - 05/2010
5	Movement Disorders (Movement Disorder) 10/2020 - 01/2015
4	Lewy Body Disease (Lewy Body Dementia) 01/2024 - 01/2018
4	Anosmia 01/2023 - 09/2011
4	Tremor (Tremors) 01/2022 - 11/2013
4	Disorders of Excessive Somnolence (Hypersomnia) 01/2020 - 10/2011
3	Melanoma (Melanoma, Malignant) 04/2024 - 01/2022
3	Amyloid Plaque 01/2023 - 02/2013
3	Parkinsonian Disorders (Parkinsonism) 11/2021 - 07/2011
3	REM Sleep Behavior Disorder 01/2021 - 07/2017
3	Constipation 01/2021 - 10/2011
3	Prescription Drug Overuse 01/2017 - 01/2013
2	Mental Disorders (Mental Disorder) 10/2020 - 05/2016
2	Sleep Initiation and Maintenance Disorders (Insomnia) 12/2019 - 10/2011
2	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 01/2018 - 11/2017
2	Frontotemporal Dementia (Semantic Dementia) 01/2018 - 11/2017
2	Dizziness (Lightheadedness) 01/2016 - 04/2010
2	Fatigue 01/2015 - 10/2011
2	Depressive Disorder (Melancholia) 09/2003 - 08/2003
1	Gaucher Disease (Gaucher's Disease) 04/2024
1	Overactive Urinary Bladder (Overactive Bladder) 10/2023
1	Peripheral Nervous System Diseases (PNS Diseases) 01/2023
1	Epilepsy (Aura) 01/2023
1	Prodromal Symptoms 10/2022
1	Frontotemporal Lobar Degeneration (Degeneration, Frontotemporal Lobar) 04/2021

Drug/Important Bio-Agent (IBA)

48	Biomarkers (Surrogate Marker)IBA 05/2024 - 04/2011
19	Dopamine (Intropin)FDA LinkGeneric 01/2024 - 12/2007
15	Antidepressive Agents (Antidepressants)IBA 10/2020 - 09/2003
14	Amyloid (Amyloid Fibrils)IBA 02/2024 - 02/2013
13	Antipsychotic Agents (Antipsychotics)IBA 12/2022 - 10/2006
13	Citalopram FDA LinkGeneric 05/2016 - 10/2011
12	SynucleinsIBA 05/2024 - 01/2015
11	Apolipoproteins E (ApoE)IBA 01/2023 - 04/2012
10	Levodopa (L Dopa)FDA LinkGeneric 06/2023 - 10/2006
10	Dopamine Agonists (Dopamine Agonist)IBA 10/2020 - 07/2006
9	Dopamine Plasma Membrane Transport Proteins (Dopamine Transporter)IBA 01/2021 - 02/2005
7	Amyloid beta-PeptidesIBA 01/2024 - 01/2016
7	pimavanserinIBA 12/2023 - 02/2017
7	Sertraline (Zoloft)FDA LinkGeneric 01/2014 - 08/2003
5	Neurotransmitter Agents (Neurotransmitter)IBA 01/2024 - 09/2015
5	Quetiapine Fumarate (Seroquel)FDA Link 01/2023 - 10/2006
4	Proteins (Proteins, Gene)FDA Link 06/2022 - 04/2011
3	alpha-SynucleinIBA 01/2024 - 01/2017
3	ApolipoproteinsIBA 01/2022 - 04/2012
3	Cholinergic Antagonists (Anticholinergics)IBA 11/2021 - 01/2019
3	Memantine (Namenda)FDA Link 03/2016 - 10/2011
3	Rivastigmine (Exelon)FDA LinkGeneric 06/2015 - 09/2011
3	Olanzapine (Zyprexa)FDA Link 10/2011 - 12/2003
3	Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA 10/2011 - 01/2006
2	IgA receptor (protein B)IBA 04/2024 - 01/2022
2	Glycoproteins (Glycoprotein)IBA 04/2024 - 01/2022
2	Muscarinic AntagonistsIBA 10/2023 - 11/2021
2	Dopamine Receptors (Dopamine Receptor)IBA 10/2022 - 08/2009
2	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA 06/2022 - 04/2012
2	Anti-Anxiety Agents (Anxiolytics)IBA 01/2020 - 06/2007
2	Phosphotransferases (Kinase)IBA 01/2020 - 01/2018
2	Hypnotics and Sedatives (Sedatives)IBA 01/2020 - 03/2016
2	Glucosylceramidase (Glucocerebrosidase)IBA 01/2020 - 01/2018
2	Leucine (L-Leucine)FDA Link 01/2020 - 01/2018
2	Cholinesterase Inhibitors (Anticholinesterases)IBA 01/2019 - 09/2015
2	rasagiline (Azilect)FDA Link 01/2016 - 01/2015
2	Epidermal Growth Factor (EGF)IBA 01/2016 - 04/2011
2	Naltrexone (ReVia)FDA LinkGeneric 03/2015 - 08/2014
2	Amantadine (Aman)FDA LinkGeneric 10/2011 - 12/2010
2	Pramipexole (Mirapex)FDA LinkGeneric 10/2011 - 06/2010
2	Clozapine (Clozaril)FDA LinkGeneric 10/2011 - 12/2003
2	Risperidone (Risperdal Consta)FDA LinkGeneric 10/2006 - 12/2003
1	AntibodiesIBA 05/2024
1	chemotactic factor inactivatorIBA 02/2024
1	EpitopesIBA 01/2024
1	mirabegronIBA 10/2023
1	Levetiracetam (Keppra)FDA LinkGeneric 01/2023
1	Serotonin 5-HT2 Receptor AntagonistsIBA 01/2023
1	Gabapentin (Neurontin)FDA LinkGeneric 01/2023
1	Pregabalin (Lyrica)FDA Link 01/2023
1	Glial Fibrillary Acidic ProteinIBA 01/2023
1	Threonine (L-Threonine)FDA Link 01/2023
1	brivaracetamIBA 01/2023
1	Serotonin ReceptorsIBA 10/2022
1	antiarrhythmic peptide (AAP)IBA 10/2022
1	Dichlororibofuranosylbenzimidazole (DRB)IBA 10/2022
1	C-Reactive ProteinIBA 01/2022
1	AlbuminsIBA 01/2022

Therapy/Procedure

18	Therapeutics 01/2024 - 12/2007
8	Activities of Daily Living (ADL) 01/2021 - 10/2008
6	Deep Brain Stimulation 06/2023 - 09/2005
3	Home Nursing (Nursing, Home) 11/2023 - 08/2003
2	Precision Medicine 01/2024 - 01/2021
1	Ambulatory Care (Outpatient Care) 11/2023